List of works - Mark Slee

A case of valproate induced hyperammonemic encephalopathy

scientific article published on 4 May 2011

A new era in the treatment of multiple sclerosis

scientific article (publication date: 3 August 2015)

A novel mitochondrial DNA deletion producing progressive external ophthalmoplegia associated with multiple sclerosis

scientific article published on 26 July 2011

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

scientific article published on 29 September 2013

Anti-inflammatory disease modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study

scientific article published on 02 November 2018

Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis

scientific article published on 01 November 2018

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

scientific article published on 01 January 2019

CSF hypotension: A review of its manifestations, investigation and management.

scientific article

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.

scientific article

Clinical, electrophysiological and genetic features of a large Australian family with paramyotonia congenita.

scientific article published in March 2009

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

scientific article published on 5 December 2014

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

scientific article published on 13 January 2019

Contribution of different relapse phenotypes to disability in multiple sclerosis.

scientific article published on 7 April 2016

Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome

scientific article

Data quality evaluation for observational multiple sclerosis registries

scientific article

Defining reliable disability outcomes in multiple sclerosis

scientific article published on 10 September 2015

Defining secondary progressive multiple sclerosis

scientific article published on 7 July 2016

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

scientific article published on 13 June 2016

Evaluating the Ability of Open-Source Artificial Intelligence to Predict Accepting-Journal Impact Factor and Eigenfactor Score Using Academic Article Abstracts: Cross-sectional Machine Learning Analysis

scientific article published in 2023

Fluctuations of MS births and UV-light exposure.

scientific article

Genetic variants are major determinants of CSF antibody levels in multiple sclerosis

scientific article published on 22 January 2015

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

scientific article

Geographical variations in sex ratio trends over time in multiple sclerosis.

scientific article

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

scientific article published on 3 November 2016

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

scientific article published on 28 September 2016

Incidence and prevalence of NMOSD in Australia and New Zealand.

scientific article published on 26 May 2017

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study

scientific article published on 03 January 2019

Increasing age at disability milestones among MS patients in the MSBase Registry

scientific article published on 14 April 2012

Late effects of oxaliplatin-induced peripheral neuropathy (LEON)--cross-sectional cohort study of patients with colorectal cancer surviving at least 2 years

scientific article published on 16 September 2014

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

scientific article published on April 2017

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

scientific article published on 5 June 2015

Multifocal motor neuropathy: the diagnostic spectrum and response to treatment

scientific article published on 01 October 2007

Muscle-specific kinase antibody positive myaesthenia gravis and multiple sclerosis co-presentation: a case report and literature review.

scientific article

Neuromyelitis optica (Devic's disease) in a patient with syphilis

scientific article published on 6 November 2007

Parkinsonism and dementia due to gliomatosis cerebri mimicking sporadic Creutzfeldt-Jakob disease (CJD).

scientific article published on February 2006

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

scientific article

Predictors and dynamics of postpartum relapses in women with multiple sclerosis.

scientific article

Predictors of disability worsening in clinically isolated syndrome.

scientific article published on 27 March 2015

Relapsing encephalopathy with headache: an unusual presentation of isolated intracranial neurosarcoidosis

scientific article published on July 2007

Relapsing necrotising encephalomyelopathy due to RANBP2 mutation

scientific article published on 22 February 2019

Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study

scientific article

Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season.

scientific article published on 14 October 2013

Risk of relapse phenotype recurrence in multiple sclerosis.

scientific article

Risk of secondary progressive multiple sclerosis: A longitudinal study

scientific article published on 09 August 2019

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

scientific article published on 20 October 2014

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

scientific article published on 18 October 2013

Speech-activated myoclonus: an uncommon form of action myoclonus

scientific article published in September 2005

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

scientific article published on 17 January 2015

The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform

scientific article

The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry

The Northern Territory Medical Program - growing our own in the NT

scientific article published on 27 May 2019

The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease

scientific article

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

scientific article published on 21 July 2015

The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude

scientific article published on 20 December 2011

The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis

article

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurolo

scientific article published on 30 June 2014

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association o

scientific article

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of

scientific article published on 30 June 2014

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

scientific article published in September 2017

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.

scientific article published on 10 February 2017

List of works by Mark Slee

A case of valproate induced hyperammonemic encephalopathy

A new era in the treatment of multiple sclerosis

A novel mitochondrial DNA deletion producing progressive external ophthalmoplegia associated with multiple sclerosis

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

Anti-inflammatory disease modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study

Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

CSF hypotension: A review of its manifestations, investigation and management.

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.

Clinical, electrophysiological and genetic features of a large Australian family with paramyotonia congenita.

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

Contribution of different relapse phenotypes to disability in multiple sclerosis.

Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome

Data quality evaluation for observational multiple sclerosis registries

Defining reliable disability outcomes in multiple sclerosis

Defining secondary progressive multiple sclerosis

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

Evaluating the Ability of Open-Source Artificial Intelligence to Predict Accepting-Journal Impact Factor and Eigenfactor Score Using Academic Article Abstracts: Cross-sectional Machine Learning Analysis

Fluctuations of MS births and UV-light exposure.

Genetic variants are major determinants of CSF antibody levels in multiple sclerosis

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

Geographical variations in sex ratio trends over time in multiple sclerosis.

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

Incidence and prevalence of NMOSD in Australia and New Zealand.

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study

Increasing age at disability milestones among MS patients in the MSBase Registry

Late effects of oxaliplatin-induced peripheral neuropathy (LEON)--cross-sectional cohort study of patients with colorectal cancer surviving at least 2 years

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

Multifocal motor neuropathy: the diagnostic spectrum and response to treatment

Muscle-specific kinase antibody positive myaesthenia gravis and multiple sclerosis co-presentation: a case report and literature review.

Neuromyelitis optica (Devic's disease) in a patient with syphilis

Parkinsonism and dementia due to gliomatosis cerebri mimicking sporadic Creutzfeldt-Jakob disease (CJD).

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

Predictors and dynamics of postpartum relapses in women with multiple sclerosis.

Predictors of disability worsening in clinically isolated syndrome.

Relapsing encephalopathy with headache: an unusual presentation of isolated intracranial neurosarcoidosis

Relapsing necrotising encephalomyelopathy due to RANBP2 mutation

Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study

Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season.

Risk of relapse phenotype recurrence in multiple sclerosis.

Risk of secondary progressive multiple sclerosis: A longitudinal study

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

Speech-activated myoclonus: an uncommon form of action myoclonus

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform

The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry

The Northern Territory Medical Program - growing our own in the NT

The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude

The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurolo

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association o

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.